These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 17218764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
    Fischer H, Huber V, Boknik P, Luess H, Neumann J, Schmitz W, Domschke W, Konturek JW.
    Microsc Res Tech; 2001 Jun 01; 53(5):336-42. PubMed ID: 11376494
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
    Konturek PC, Kania J, Gessner U, Konturek SJ, Hahn EG, Konturek JW.
    Eur J Pharmacol; 2004 Dec 15; 506(2):169-77. PubMed ID: 15588738
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats with functional ablation of sensory nerves.
    Konturek PC, Brzozowski T, Kania J, Konturek SJ, Hahn EG.
    Inflamm Res; 2003 Sep 15; 52(9):359-65. PubMed ID: 14504662
    [Abstract] [Full Text] [Related]

  • 10. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
    Kordecki H, Kurowski M, Kosik R, Pilecka D.
    J Physiol Pharmacol; 1997 Sep 15; 48 Suppl 4():85-91. PubMed ID: 9440059
    [Abstract] [Full Text] [Related]

  • 11. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects.
    Anand BS, Romero JJ, Sanduja SK, Lichtenberger LM.
    Am J Gastroenterol; 1999 Jul 15; 94(7):1818-22. PubMed ID: 10406241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis.
    Franco L, Talamini G.
    Med Princ Pract; 2009 Jul 15; 18(6):477-81. PubMed ID: 19797925
    [Abstract] [Full Text] [Related]

  • 18. Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels.
    Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Mönkemüller K, Malfertheiner P.
    Scand J Gastroenterol; 2008 Jul 15; 43(7):801-9. PubMed ID: 18584518
    [Abstract] [Full Text] [Related]

  • 19. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species.
    Brzozowski T, Kwiecień S, Konturek PC, Konturek SJ, Mitis-Musiol M, Duda A, Bielański W, Hahn EG.
    Med Sci Monit; 2001 Jul 15; 7(4):592-9. PubMed ID: 11433182
    [Abstract] [Full Text] [Related]

  • 20. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin.
    Brzozowski T, Konturek P, Konturek SJ, Kwiecień S, Sliwowski Z, Pajdo R, Duda A, Ptak A, Hahn EG.
    Int J Colorectal Dis; 2003 Jul 15; 18(4):320-9. PubMed ID: 12774247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.